Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRR1B | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | TMEM263 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | B3GNT2 | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
mRNA | MFSD4A | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | PTPRN2 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
mRNA | MSX1 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | NABP2 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | THEM4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | DNAJC18 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
mRNA | KLK7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |